David Englert

Technik-/Wissenschafts-/F&E-Leiter bei Axela, Inc.

Health Technology

Consumer Services

Aktive Positionen von David Englert

Unternehmen	Position	Beginn	Ende
Axela, Inc. Axela, Inc. Medical SpecialtiesHealth Technology Axela, Inc. develops biosensor technology. It offers next generation, commercial stage, multiplex tools that provide enhanced analysis of proteins, DNA and RNA. The firm’s products include Ziplex System, autograph, metabolic, colon and breast cancer, inflammation Xpress chips, diffractive optics technology and sensors, dotLab mX System and dot-Avidin, Ready and Covalent products. The company was founded by M. Cynthia Goh, Richard Loo, B. Jane Goh and Richard McAloney in 2001 and is headquartered in Toronto, Canada.	Technik-/Wissenschafts-/F&E-Leiter	30.08.2011	-

Unternehmen	Position	Beginn	Ende
Pharmacia LKB Biotechnology, Inc.	Corporate Officer/Principal	-	-

The State University of New York

Doctorate Degree

International

Vereinigte Staaten	3
Kanada	2

Operativ

Chief Tech/Sci/R&D Officer	1
Doctorate Degree	1
Corporate Officer/Principal	1

Sektoral

Health Technology	2
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Private Unternehmen	2
Axela, Inc. Axela, Inc. Medical SpecialtiesHealth Technology Axela, Inc. develops biosensor technology. It offers next generation, commercial stage, multiplex tools that provide enhanced analysis of proteins, DNA and RNA. The firm’s products include Ziplex System, autograph, metabolic, colon and breast cancer, inflammation Xpress chips, diffractive optics technology and sensors, dotLab mX System and dot-Avidin, Ready and Covalent products. The company was founded by M. Cynthia Goh, Richard Loo, B. Jane Goh and Richard McAloney in 2001 and is headquartered in Toronto, Canada.	Health Technology
Pharmacia LKB Biotechnology, Inc.

Private Unternehmen

Health Technology

Pharmacia LKB Biotechnology, Inc.